Results 271 to 280 of about 6,606,497 (285)

Safety and effectiveness of tacrolimus add-on therapy for rheumatoid arthritis patients without an adequate response to biological disease-modifying anti-rheumatic drugs (DMARDs): Post-marketing surveillance in Japan

Modern Rheumatology, 2018
Tsutomu Takeuchi
exaly  

Nifedipine OROS in Chinese patients with hypertension – results of a post‐marketing surveillance study in Taiwan

Blood Pressure, 2005
Yi-Jen Hung, Kuo-Chun Hung, Poh-Shiow Yeh   +2 more
exaly  

Post-marketing surveillance study of the long-term use of mizoribine for the treatment of lupus nephritis: 2-Year results

Modern Rheumatology, 2018
Hisao Yoshida, Tsutomu Takeuchi
exaly  

Post-Marketing Surveillance

2002
openaire   +1 more source

Safety and efficacy of canagliflozin in elderly patients with type 2 diabetes mellitus: a 1-year post-marketing surveillance in Japan

Current Medical Research and Opinion, 2018
Kazuyo Sasaki
exaly  

Safety and efficacy of long-term treatment with teneligliptin: Interim analysis of a post-marketing surveillance of more than 10,000 Japanese patients with type 2 diabetes mellitus

Expert Opinion on Pharmacotherapy, 2018
Kazuyo Sasaki, Motohiro Sasaki, Masakazu Haneda   +2 more
exaly  

Zolpidem in Insomnia: A 3-Year Post-Marketing Surveillance Study in Switzerland

Journal of International Medical Research, 1995
exaly  

Patient and Physician Satisfaction with Rofecoxib in Osteoarthritis: Results of a Post-marketing Surveillance Study in Primary Care in Germany

Current Medical Research and Opinion, 2002
exaly  

Problems of post-marketing surveillance

Reactions, 1984
openaire   +1 more source

Improvements for Post-Marketing Surveillance

Emergency Medicine News, 2005
openaire   +1 more source